OSE Immunotherapeutics SA (ORPOF)
Market Closed
12 Jun, 20:00
$
4. 43
0
0%
$
- Market Cap
- P/E Ratio
- Div Yield
3,500 Volume
- Eps
$ 4.43
Previous Close Want to track ORPOF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
OSE Immunotherapeutics SA (ORPOF) Statistics
Valuation metrics
Market Cap -
Enterprise value 105.89M
Trailing P/E (ttm) -2.32
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 33.63
Price/Book (mrq) 3.19
Enterprise Value/Revenue 40.43
Enterprise Value/EBITDA -2.36
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) 125
Price summary
52-Week low 4.43
52-Week high 11.6
Beta -
50-Day moving average 5.73
200-Day moving average 10.97
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -14.39%
Operating margin -18.35%
Operational effectiveness
Return on assets -0.48%
Return on equity -0.97%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.12
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.68
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.01
Total debt (mrq) -
Total Debt/Equity (mrq) 1.29
Current ratio (mrq) 1.28%
Book value per share (mrq) 1.22
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
